Sanofi-Aventis to invest in R&D in Spain
Business Investments
01 Apr 2012
France-based pharmaceutical company Sanofi-aventis plans to invest $1.3 million in research and development (R&D) projects of Barcelona's international biomedical research institute CRG.
The projects include cell reprogramming, the application of synthetic biology technology to treat lung diseases, the influence of genes as factor for some diseases and tuberculosis treatment, the director of CRG, Luis Serrano, said.
Source: IPA WORLD, 8/3/2012
Related News and Success stories.
-
22 Jan 2025
See more Airbus GeoTech: How Catalonia’s innovation and talent drive Geospatial Data ExcellenceAirbus GeoTech: How Catalonia’s innovation and talent drive Geospatial Data Excellence
-
17 Jan 2025
See more ICL and Dynanonic to invest €285M in a new plant for battery materials in CataloniaICL and Dynanonic to invest €285M in a new plant for battery materials in Catalonia
-
15 Jan 2025
See more s360 opens a new office in Barcelona to boost European expansions360 opens a new office in Barcelona to boost European expansion
-
14 Jan 2025
See more Austrian company Amiblu invests €4.2 million, creating 70 jobs in TarragonaAustrian company Amiblu invests €4.2 million, creating 70 jobs in Tarragona
